ORA
JPMorgan hit the brakes
JPMorgan Chase & Co. trimmed its price target on Ormat Technologies to $106. That’s the kind of move that doesn’t scream disaster, but it does whisper, “We’re not exactly getting carried away here.”
The quarter wasn’t the problem
Ormat also posted quarterly EPS of $0.67, matching estimates, while revenue came in at $276.04 million versus the Street’s $257.75 million call. So the company didn’t trip over its own shoelaces on the earnings front — it actually outpaced revenue expectations.
Why investors should care
Analyst price-target cuts can matter because they often nudge sentiment before the stock does. If you own ORA, this is a reminder that even decent results don’t always translate into higher expectations. Wall Street may be saying the growth story is real, but the next leg up might need more than a solid quarter.
The fine print
There’s also some background noise in the article: insider Jessica Woelfel sold 2,359 shares on March 3rd, and analysts now expect Ormat to earn 1.94 per share for the full year. None of that screams panic, but it does add a little “show me” energy to the stock.
Big picture: Ormat is still doing the basic job — growing revenue and meeting profit targets — but JPMorgan’s lower target suggests the easy optimism may already be priced in.